97 results
Page 5 of 5
8-K
EX-99.1
j1lph
12 Jun 18
Viking Therapeutics Announces Closing of Public Offering of Common Stock
7:10am
424B5
9mlblk3d4tx
7 Jun 18
Prospectus supplement for primary offering
5:13pm
8-K
EX-99.1
92we2dpw
7 Jun 18
Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock
1:41pm
424B5
pcqbsyz
6 Jun 18
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.1
dk091
9 May 18
Viking Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
12:00am
424B4
pe4cs8bb cll
8 Apr 16
Prospectus supplement with pricing info
12:00am
10-K
qojo3utf1 aim5hsyk0
8 Mar 16
Annual report
12:00am
10-Q
iuug 0w4gj47be
12 Jun 15
Quarterly report
12:00am